Ilona Kryczek

30.6k total citations · 8 hit papers
93 papers, 13.7k citations indexed

About

Ilona Kryczek is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ilona Kryczek has authored 93 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Immunology, 52 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Ilona Kryczek's work include Immune Cell Function and Interaction (43 papers), Immunotherapy and Immune Responses (34 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Ilona Kryczek is often cited by papers focused on Immune Cell Function and Interaction (43 papers), Immunotherapy and Immune Responses (34 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Ilona Kryczek collaborates with scholars based in United States, China and Poland. Ilona Kryczek's co-authors include Weiping Zou, Shuang Wei, Wojciech Szeliga, Linda Vatan, Ende Zhao, Theodore H. Welling, Pui Cheng, Linhua Vatan, Linhua Zou and Nisha Nagarsheth and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ilona Kryczek

90 papers receiving 13.5k citations

Hit Papers

Fusobacterium nucleatum Promotes Chemo... 2006 2026 2012 2019 2017 2015 2009 2022 2006 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
    2017 1.6k citations Yanan Yu, Ilona Kryczek et al. profile →
  2. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
    2015 893 citations Dongjun Peng, Ilona Kryczek et al. profile →
  3. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
    2009 623 citations Ilona Kryczek, Pui Cheng et al. profile →
  4. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
    2022 582 citations Ilona Kryczek, Li Xiong et al. profile →
  5. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
    2006 581 citations Ilona Kryczek, Linhua Zou et al. profile →
  6. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
    2017 579 citations Tomasz Maj, Wei Wang et al. profile →
  7. Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
    2014 540 citations Ende Zhao, Ilona Kryczek et al. profile →
  8. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
    2018 449 citations Shuang Wei, Michael D. Green et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilona Kryczek United States 45 8.0k 6.5k 4.4k 1.9k 1.4k 93 13.7k
Nathalie Chaput France 45 5.6k 0.7× 5.7k 0.9× 4.5k 1.0× 1.8k 0.9× 1.6k 1.1× 144 11.7k
Vassiliki A. Boussiotis United States 61 9.5k 1.2× 5.5k 0.8× 3.8k 0.9× 1.3k 0.7× 883 0.6× 182 15.6k
Michele W.L. Teng Australia 56 8.3k 1.0× 9.2k 1.4× 3.6k 0.8× 1.4k 0.8× 1.9k 1.4× 95 15.0k
Augusto C. Ochoa United States 52 10.4k 1.3× 4.9k 0.7× 3.2k 0.7× 1.5k 0.8× 794 0.6× 127 14.4k
Hiroyoshi Nishikawa Japan 54 9.1k 1.1× 8.1k 1.2× 2.9k 0.7× 1.1k 0.6× 1.6k 1.2× 187 14.3k
Marie‐Caroline Dieu‐Nosjean France 53 8.7k 1.1× 7.2k 1.1× 2.1k 0.5× 1.1k 0.6× 1.9k 1.4× 88 13.5k
Greg M. Delgoffe United States 48 7.7k 1.0× 4.3k 0.7× 3.8k 0.9× 2.2k 1.1× 627 0.5× 109 11.9k
Salem Chouaı̈b France 69 8.9k 1.1× 6.3k 1.0× 6.0k 1.4× 3.9k 2.0× 1.4k 1.0× 328 17.2k
Qing Yi United States 54 4.9k 0.6× 3.6k 0.5× 3.8k 0.9× 1.7k 0.9× 851 0.6× 197 9.8k
Koji Tamada Japan 54 11.8k 1.5× 10.6k 1.6× 2.8k 0.6× 863 0.5× 1.4k 1.0× 147 17.4k

Countries citing papers authored by Ilona Kryczek

Since Specialization
Citations

This map shows the geographic impact of Ilona Kryczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Kryczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Kryczek more than expected).

Fields of papers citing papers by Ilona Kryczek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilona Kryczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Kryczek. The network helps show where Ilona Kryczek may publish in the future.

Co-authorship network of co-authors of Ilona Kryczek

This figure shows the co-authorship network connecting the top 25 collaborators of Ilona Kryczek. A scholar is included among the top collaborators of Ilona Kryczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilona Kryczek. Ilona Kryczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zakharia, Yousef, Eric A. Singer, Rohan Garje, et al.. (2024). Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043. Nature Communications. 15(1). 972–972. 6 indexed citations
2.
Thibodeaux, Suzanne R., Srilakshmi Pandeswara, Vincent Hurez, et al.. (2021). IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Clinical Cancer Research. 27(13). 3661–3673. 12 indexed citations
3.
Xia, Houjun, Shasha Li, Xiong Li, et al.. (2020). Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. JCI Insight. 5(18). 91 indexed citations
4.
Zhang, Qiang, Michael D. Green, Xueting Lang, et al.. (2019). Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Cancer Research. 79(15). 3940–3951. 150 indexed citations
5.
Yan, Tingting, Linlin Ren, Chaoqin Shen, et al.. (2018). miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer. Cancer Research. 78(7). 1751–1765. 23 indexed citations
6.
Li, Wei, Takashi Tanikawa, Ilona Kryczek, et al.. (2018). Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism. 28(1). 87–103.e6. 326 indexed citations
7.
Xia, Houjun, Wei Wang, Joel Crespo, et al.. (2017). Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity. Science Immunology. 2(17). 119 indexed citations
8.
Nagarsheth, Nisha, Dongjun Peng, Ilona Kryczek, et al.. (2015). PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Research. 76(2). 275–282. 213 indexed citations
9.
Kryczek, Ilona, Ende Zhao, Yan Liu, et al.. (2012). Human Th17 cells have stem cell-like features and promote long-term tumor immunity (122.10). The Journal of Immunology. 188(1_Supplement). 122.10–122.10. 1 indexed citations
10.
Tanikawa, Takashi, Cailin Moira Wilke, Ilona Kryczek, et al.. (2011). Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis. Cancer Research. 72(2). 420–429. 119 indexed citations
11.
Mazur, Grzegorz, Emilia Jaskuła, Ilona Kryczek, et al.. (2011). Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma. Folia Histochemica et Cytobiologica. 49(2). 240–247. 19 indexed citations
12.
Mazur, Grzegorz, Emilia Jaskuła, Ilona Kryczek, et al.. (2011). Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Kryczek, Ilona, Rebecca Liu, Guobin Wang, et al.. (2009). FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease. Cancer Research. 69(9). 3995–4000. 151 indexed citations
14.
Wu, Ke, Ilona Kryczek, Lieping Chen, Weiping Zou, & Theodore H. Welling. (2009). Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions. Cancer Research. 69(20). 8067–8075. 313 indexed citations
15.
Barnett, Brian, Jens Rüter, Ilona Kryczek, et al.. (2008). Regulatory T cells. Advances in experimental medicine and biology. 622. 255–260. 3 indexed citations
16.
Kryczek, Ilona, Allen T. Bruce, Jóhann E. Guðjónsson, et al.. (2008). Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis. The Journal of Immunology. 181(7). 4733–4741. 372 indexed citations
17.
Curiel, Tyler J., Brian Barnett, Ilona Kryczek, Pui Cheng, & Weiping Zou. (2006). Regulatory T cells in ovarian cancer: biology and therapeutic potential. 6. 20. 9 indexed citations
18.
Kryczek, Ilona, Shuang Wei, Linhua Zou, et al.. (2006). Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells. The Journal of Immunology. 177(1). 40–44. 219 indexed citations
19.
Curiel, Tyler J., Pui Cheng, Peter Mottram, et al.. (2004). Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer. Cancer Research. 64(16). 5535–5538. 228 indexed citations
20.
Lange, Andrzej, et al.. (2003). Biological and clinical impact of IL-6 production by ovarian carcinoma cells. Contemporary Oncology/Współczesna Onkologia. 3(5). 195–198. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Chaput Breakdown of academic impact, for papers by Vassiliki A. Boussiotis Breakdown of academic impact, for papers by Michele W.L. Teng Breakdown of academic impact, for papers by Augusto C. Ochoa Breakdown of academic impact, for papers by Hiroyoshi Nishikawa Breakdown of academic impact, for papers by Marie‐Caroline Dieu‐Nosjean Breakdown of academic impact, for papers by Greg M. Delgoffe Breakdown of academic impact, for papers by Salem Chouaı̈b Breakdown of academic impact, for papers by Qing Yi Breakdown of academic impact, for papers by Koji Tamada
Rankless by CCL
2026